
Founder Friday: Weijie Poh & Josh Wang of Pathovax
Imagine the possibility of not just curing one variation of a type of cancer, but all variations. Game changer, right? That’s exactly what 2016 Winner PathoVax is determined to accomplish. Their HPV vaccine, RGVax, targets all 15 types of HPV that cause cervical cancer and other cancers, where current vaccines on the market only target a